Angewandte
Chemie
introduced by peptide coupling between 2-(pyridin-2-yl)pro-
pan-2-amine and Bn-protected d-lactic acid, the latter being
accessible in two steps and quantitative yield from commer-
cially available methyl d-lactate (15). After screening various
methyl ester was subsequently hydrolyzed. The coupling of
the resulting carboxylic acid with the Cbz-protected agmatine
3a furnished the intermediate 19 in high yield. The latter
underwent sulfation under previously reported reaction
conditions,[3i] followed by hydrogenolysis of all four benzyl-
containing protecting groups to give aeruginosin 98B (37 mg).
The synthetic product, which showed identical spectroscopic
data to previously reported compounds,[2b,3i] was obtained in
5.1% overall yield (84% average yield per step) for the
longest linear sequence of 17 steps starting from 9. In
principle, the same synthetic sequence employing 5b,c instead
of 5a would lead to aeruginosins 98A and 98C (Table 1). In
these cases, the final hydrogenation step is challenging
because of the presence of sensitive carbon–halogen bonds.
Studies towards these targets are currently on-going in our
laboratory and will be reported in due course.
Following this first success, we decided to perform the
synthesis of our second target, aeruginosin 298A (1d), on
a larger scale. The compound 1d possesses the same Choi core
and Hpla fragment as aeruginosin 98B, but a different hydro-
phobic amino acid and C-terminus (Scheme 5). First, 5a was
reacted with d-leucine methyl ester on gram scale, and the
resulting product 20 was hydrolyzed and coupled with 2,
thereby providing the intermediate 21. Then, similarly as
above with 1b, cleavage of the TBDPS group, followed by
ester hydrolysis and coupling with the protected l-argol
fragment 3b, which was synthesized through an improved
protocol starting from Boc-protected l-ornithine in four steps
(55% overall yield; Scheme 5, bottom), furnished 1.9 g of the
intermediate 22 in excellent yield from 21. Finally, acid-
mediated cleavage of the TBS group on the
ꢀ
reported reaction conditions for the C H arylation of 7 with
the benzyl-protected iodoarene 8a under palladium(II)
acetate catalysis, we found that K2CO3 as the base and
acetonitrile as the solvent allowed isolation of the aryllactate
16a in an optimal 78% yield. Notably, this procedure could be
conducted on gram scale without any racemization despite
the use of basic conditions, as verified by HPLC analysis on
a chiral stationary phase employing independently prepared
racemic samples of 7 and 16a as references. To remove the
PIP directing group in 16a without racemization of the base-
sensitive stereocenter, we designed a new, very mild protocol
employing NOBF4 as a nitrosation agent[13] and pyridine at
low temperature. In this manner, the enantiopure carboxylic
ꢀ
acid 5a was obtained in excellent yield. The same C H
arylation/PIP cleavage sequence was then applied to the
halogenated iodoarenes 8b,c, which are relevant to the
synthesis of halogenated aeruginosins 98A and 98C, thereby
furnishing the halogenated Hpla fragments 5b,c chemoselec-
tively and in good overall yields.
With the various requisite fragments in hand, we turned to
the synthesis of our first target, aeruginosin 98B (1b;
Scheme 4). First, 5a was reacted with d-allo-isoleucine
methyl ester[3i,14] under classical peptide coupling conditions
to give the intermediate 17, which upon hydrolysis and
peptide coupling with 2 gave the methyl ester 18. Then, the
TBDPS group of 2 was removed using Olahꢀs reagent, and the
argol fragment and hydrogenolysis provided
700 mg of 1d, which was isolated as the salt
formed with trifluoroacetic acid, as described
previously.[2a,3b,e,g] Remarkably, the synthetic
product was obtained in 8.2% overall yield
(86% average yield per step) for the longest
linear sequence of 17 steps starting from 9.
Both the overall yield and scale of this total
synthesis are unprecedented.[15]
In conclusion, we have provided a general
and scalable access to the aeruginosin family
of marine natural products possessing inter-
esting pharmacological properties, albeit low
availability from natural sources. For this
3
ꢀ
purpose, two recently discovered C(sp ) H
activation reactions were employed in a stra-
tegic manner, with the first one enabling
a large-scale synthesis of the common (Choi)
heterocyclic core of the molecules and the
second one a rapid and divergent access to
diversely decorated Hpla fragments. This
powerful strategy was successfully imple-
mented in the synthesis of aeruginosins 98B
and 298A, with the latter being performed on
unprecedentedly large scale, and should
streamline the access to other members of
this family of marine products, including the
halogenated congeners. Importantly, this
Scheme 4. Synthesis of aeruginosin 98B (1b). Reagents and conditions: a) d-allo-Ile-
OMe, PyBOP, iPr2NEt, CH2Cl2, 208C, 77%; b) LiOH, THF/MeOH 3:1, 0!208C; c) 2
(1.2 equiv), PyBOP, iPr2NEt, CH2Cl2, 208C, 60% for 2 steps; d) HF·pyridine, CH3CN,
08C, 95%; e) LiOH, THF/MeOH (2:1), 0!208C; f) 3a (1.2 equiv), HBTU, iPr2NEt,
DMF, 0!208C, 100% for 2 steps; g) SO3·pyridine, pyridine, 508C; h) H2, Pd(OH)2/C,
MeOH/AcOEt (1:1), 208C, 60% for 2 steps. PyBOP=(benzotriazol-1-yloxy)tripyrrolidino-
phosphonium hexafluorophosphate, THF=tetrahydrofuran.
Angew. Chem. Int. Ed. 2015, 54, 1 – 5
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3
These are not the final page numbers!